Cite
MLA Citation
Scott JC Pallett et al.. “4 Early identification of high-risk individuals for combination monoclonal antibody therapy is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay.” BMJ military health, vol. 168, no. 5, 2022, p. e1. http://access.bl.uk/ark:/81055/vdc_100167559119.0x000004